SERPINB2 and breast cancer: The in vitro cytotoxicity of 213Bi-PAI2 on breast cancer cells was shown to be specific, indicating that the cell killing ability of 213Bi-PAI2 depends critically on the targeting of cells in a receptor-bound, active uPA-dependent manner (Ranson et al, 2002).